Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
It has been known that liraglutide reduces infarct size, improved left ventricular function,
reduce myocardial stunning, and play a protective role in myocardial ischemia-reperfusion
injury for patients with acute myocardial infarction. But it is not sure whether liraglutide
can benefit patients with ischemic cardiomyopathy. This study aim to explore the effect of
Liraglutide in improving cardiac function for patients with ischemic cardiomyopathy.